References
- Edwards J E, Jr. Invasive Candida infections. Evolution of a fungal pathogen. N Engl J Med 1991; 324: 1060–1062
- Bodey G P. Candidiasis: a growing concern. Am J Med 1984; 77: 1–48
- Prentice A G. Oral and gastrointestinal candidosis: prophylaxis during immunosuppressive therapy. Mycoses, Suppl. 1989; 2: 42–46
- Tavitian A, Raufman J P, Rosenthal L E. Oral candidiasis as a marker for esophageal candidiasis in the aquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 54–55
- Hawkins C, Armstrong D. Fungal infections in the immunocomprised host. Clin Haematol 1984; 13: 599–630
- Walsh T J, Hathorn J W, Sobel J D, Merz W G, Sanchez V, Maret S M, Buckley H R, Pfaller M A, Schaufele R, Sliva C, Navarro E, Lecciones J, Chandrasekar P, Lee J, Pizzo A. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991; 324: 1026–1031
- Wingard J R, Merz W G, Rinaldi M G, Johnson T R, Karp J E, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277
- Morace G, Manzara S, Dettori G. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Chemotherapy 1991; 37: 23–31